A specific oligodeoxynucleotide promotes the differentiation of osteoblasts via ERK and p38 MAPK pathways

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 7902-7914

  Hou, Xu ^a   Shen, Yuqin ^a   Zhang, Chao ^a   Zhang, Liru ^a   Qin, Yanyan ^a   Yu, Yongli ^a   Wang, Liying ^a   Sun, Xinhua ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Differentiation; ERK1 2 MAPK; Oligodeoxynucleotide; Osteoblast; p38 MAPK

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE MT01; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; 1,3 BUTADIENE DERIVATIVE; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; NITRILE; ODN MT01; OLIGODEOXYRIBONUCLEOTIDE; PYRIDINE DERIVATIVE; RUNX2 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; COLLAGEN TYPE 1 GENE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; MARKER GENE; OSTEOBLAST; OSTEOCALCIN GENE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ALKALINE PHOSPHATASE; BUTADIENES; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; NITRILES; OLIGODEOXYRIBONUCLEOTIDES; OSTEOBLASTS; OSTEOCALCIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TRANSCRIPTIONAL ACTIVATION;

EID: 84864352709     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13077902     Document Type: Article

References (35)

1. Jensen, E.D.; Gopalakrishnan, R.; Westendorf, J.J. Regulation of gene expression in osteoblasts. Biofactors 2010, 36, 25-32.
2. Otto, F.; Thornell, A.P.; Crompton, T.; Denzel, A.; Gilmour, K.C.; Rosewell, I.R.; Stamp, G.W.; Beddington, R.S.; Mundlos, S.; Olsen, B.R.; et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89, 765-771.
3. Mundlos, S.; Otto, F.; Mundlos, C.; Mulliken, J.B.; Aylsworth, A.S.; Albright, S.; Lindhout, D.; Cole, W.G.; Henn, W.; Knoll, J.H.; et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89, 773-779.
4. Stein, G.S.; Lian, J.B.; van Wijnen, A.J.; Stein, J.L.; Montecino, M.; Javed, A.; Zaidi, S.K.; Young, D.W.; Choi, J.Y.; Pockwinse, S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23, 4315-4329.
5. Ducy, P.; Starbuck, M.; Priemel, M.; Shen, J.; Pinero, G.; Geoffroy, V.; Amling, M.; Karsenty, G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999, 13, 1025-1036.
6. Cerkovnik, P.; Jezersek Novakovic, B.; Stegel, V.; Novakovic, S. Tumor vaccine composed of CpG ODN class C and irradiated tumor cells up-regulates the expression of genes characteristic of mature dendritic cells and of memory cells. Int. J. Oncol. 2011, 38, 1749-1758.
7. Liu, C.S.; Sun, Y.; Hu, Y.H.; Sun, L. Identification and analysis of a CpG motif that protects turbot (Scophthalmus maximus) against bacterial challenge and enhances vaccine-induced specific immunity. Vaccine 2010, 28, 4153-4161.
8. Bao, M.; Zhang, Y.; Wan, M.; Dai, L.; Hu, X.; Wu, X.; Wang, L.; Deng, P.; Wang, J.; Chen, J.; et al. Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide. Clin. Immunol. 2006, 118, 180-187.
9. Klinman, D.; Shirota, H.; Tross, D.; Sato, T.; Klaschik, S. Synthetic oligonucleotides as modulators of inflammation. J. Leukoc Biol. 2008, 84, 958-964.
10. Amcheslavsky, A.; Hemmi, H.; Akira, S.; Bar-Shavit, Z. Differential contribution of osteoclast-and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis. J. Bone Miner. Res. 2005, 20, 1692-1699.
11. Norgaard, N.N.; Holien, T.; Jonsson, S.; Hella, H.; Espevik, T.; Sundan, A.; Standal, T. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: Effects on myeloma cell apoptosis and in vitro osteoblastogenesis. J. Immunol. 2010, 185, 3131-3139.
12. Chang, J.H.; Chang, E.J.; Kim, H.H.; Kim, S.K. Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 down-regulation. Biochem. Biophys. Res. Commun. 2009, 389, 28-33.
13. Feng, Z.; Shen, Y.; Wang, L.; Cheng, L.; Wang, J.; Li, Q.; Shi, W.; Sun, X. An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. Int. J. Mol. Sci. 2011, 12, 2543-2555.
14. Shen, Y.; Feng, Z.; Lin, C.; Hou, X.; Wang, X.; Wang, J.; Yu, Y.; Wang, L.; Sun, X. An oligodeoxynucleotide that induces differentiation of bone marrow mesenchymal stem cells to osteoblasts in vitro and reduces alveolar bone loss in rats with periodontitis. Int. J. Mol. Sci. 2012, 13, 2877-2892.
15. Bennett, A.M.; Tonks, N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997, 278, 1288-1291.
16. Ge, C.; Yang, Q.; Zhao, G.; Yu, H.; Kirkwood, K.L.; Franceschi, R.T. Interactions between extracellular signal-regulated kinase 1/2 and P38 map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J. Bone Miner. Res. 2011, 27, doi: 10.1002/jbmr.561.
17. Jeong, H.M.; Han, E.H.; Jin, Y.H.; Hwang, Y.P.; Kim, H.G.; Park, B.H.; Kim, J.Y.; Chung, Y.C.; Lee, K.Y.; Jeong, H.G. Saponins from the roots of Platycodon grandiflorum stimulate osteoblast differentiation via p38 MAPK-and ERK-dependent RUNX2 activation. Food Chem. Toxicol. 2010, 48, 3362-3368.
18. Reddi, D.; Brown, S.J.; Belibasakis, G.N. Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: Involvement of the p38 MAPK. Microb. Pathog. 2011, 51, 415-420.
19. Yang, G.; Wan, M.; Zhang, Y.; Sun, L.; Sun, R.; Hu, D.; Zhou, X.; Wang, L.; Wu, X.; Yu, Y. Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice. Immunology 2010, 131, 501-512
20. Krieg, A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug. Discov. 2006, 5, 471-484.
21. Greenblatt, M.B.; Shim, J.H.; Zou, W.; Sitara, D.; Schweitzer, M.; Hu, D.; Lotinun, S.; Sano, Y.; Baron, R.; Park, J.M.; et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin. Invest. 2010, 120, 2457-2473.
22. Kawano, M.; Ariyoshi, W.; Iwanaga, K.; Okinaga, T.; Habu, M.; Yoshioka, I.; Tominaga, K.; Nishihara, T. Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem. Biophys. Res. Commun. 2011, 405, 575-580.
23. Zhang, D.; Zheng, H.; Zhao, J.; Lin, L.; Li, C.; Liu, J.; Pan, Y. Porphorymonas gingivalis induces intracellular adhesion molecule-1 expression in endothelial cells through the nuclear factor-κB pathway, but not through the p38 MAPK pathway. J. Periodontal. Res. 2011, 46, 31-38.
24. Suzuki, A.; Guicheux, J.; Palmer, G.; Miura, Y.; Oiso, Y.; Bonjour, J.P.; Caverzasio, J. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 2002, 30, 91-98.
25. Zou, W.; Amcheslavsky, A.; Bar-Shavit, Z. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J. Biol. Chem. 2003, 278, 16732-16740.
26. Wagner, E.F.; Karsenty, G. Genetic control of skeletal development. Curr. Opin. Genet. Dev. 2001, 11, 527-532.
27. Xiao, G.; Cui, Y.; Ducy, P.; Karsenty, G.; Franceschi, R.T. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: Requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol. Endocrinol. 1997, 11, 1103-1113.
28. Xiao, G.; Jiang, D.; Thomas, P.; Benson, M.D.; Guan, K.; Karsenty, G.; Franceschi, R.T. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 2000, 275, 4453-4459.
29. Franceschi, R.T.; Ge, C.; Xiao, G.; Roca, H.; Jiang, D. Transcriptional regulation of osteoblasts. Cells Tissues Organs 2009, 189, 144-152.
30. Bae, S.C.; Lee, Y.H. Phosphorylation, acetylation and ubiquitination: The molecular basis of RUNX regulation. Gene 2006, 366, 58-66.
31. Jeon, E.J.; Lee, K.Y.; Choi, N.S.; Lee, M.H.; Kim, H.N.; Jin, Y.H.; Ryoo, H.M.; Choi, J.Y.; Yoshida, M.; Nishino, N.; et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 2006, 281, 16502-16511.
32. Ge, C.; Xiao, G.; Jiang, D.; Yang, Q.; Hatch, N.E.; Roca, H.; Franceschi, R.T. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J. Biol. Chem. 2009, 284, 32533-32543.
33. Ge, C.; Yang, Q.; Zhao, G.; Yu, H.; Kirkwood, K.L.; Franceschi, R.T. Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J. Bone Miner. Res. 2012, 27, 538-551.
34. Yamaguchi, A.; Komori, T.; Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 2000, 21, 393-411.
35. Kern, B.; Shen, J.; Starbuck, M.; Karsenty, G. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J. Biol. Chem. 2001, 276, 7101-7107.